Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allogeneic stem cell transplantation in children and adolescents with acute lymphoblastic leukemia
2005-005106-23Phase 4Completed
- Sponsor
- St. Anna Children's Cancer Research Institute
- Start
- Jan 2007
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 4, open-label trial of allogeneic hematopoietic stem cell transplantation in acute lymphoblastic leukemia (ALL) (3 arms), sponsored by St. Anna Children's Cancer Research Institute. Primary endpoints: Event-free survival after allogeneic HSCT and Overall survival after allogeneic HSCT. Started Jan 2007; status: completed.
02
Drugs
allogeneic hematopoietic stem cell transplantation
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on 2005-005106-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005106-23.